Experimental murine models with high, intermediate and low levels of genetically based susceptibility to Leishmania major infection reproduce almost entire spectrum of clinical manifestations of the human disease. There are increasing non-comparative studies on immune responses against isolated antigens of L. major in different murine strains. The aim of the present study was to find out whether there is an antigen that can induce protective immune response in resistant and susceptible murine strains. To do that, crude antigenic extract of procyclic and metacyclic promastigotes of L. major was prepared and subjected to SDS-PAGE electrophoresis. Western-blotting was used to search for antigen(s) capable of raising high antibody level of IgG2a versus IgG1 in the sera of both infected resistant and susceptible strains. Two novel antigens from metacyclic promastigotes of L. major (140 and 152 kDa) were potentially able to induce specific dominant IgG2a responses in BALB/c and C57BL/6 mice. The 2 antigens also reacted with IgG antibody of cutaneous leishmaniasis patients. We confirm that 140 and 152 kDa proteins of L. major promastigotes are inducing IgG production in mice and humans.
Citations
Citations to this article as recorded by
Evaluation of
Leishmania
homolog of activated C kinase (LACK) of
Leishmania donovani
in comparison to glycoprotein 63 as a vaccine candidate against visceral leishmaniasis
Nicky Didwania, Sudipta Bhowmick, Abdus Sabur, Anirban Bhattacharya, Nahid Ali, Monica R. Mugnier Microbiology Spectrum.2025;[Epub] CrossRef
Diphencyprone reduces the CD8+ lymphocytes and IL-4 and enhences IgG2a/IgG1 ratio in pathogenicity of acute leishmania major infection in BALB/c mice Pourandokht Mousavian, Vahid Mashayekhi Goyonlo, Mohammad Javanbakht, Mahmoud Reza Jafari, Hamidreza Moosavian, Monovar Afzal Aghaei, Mohammadreza Malekzadeh Cytokine.2024; 184: 156792. CrossRef
Immunological characterization of rLdTCP1γ for its prophylactic potential against visceral leishmaniasis in hamster model Apeksha Anand, Deep Chandra Balodi, Karthik Ramalingam, Shailendra Yadav, Neena Goyal Molecular Immunology.2022; 141: 33. CrossRef
Adjuvanted vaccines driven protection against visceral infection in BALB/c mice by Leishmania donovani Deepak Kumar Goyal, Poonam Keshav, Sukhbir Kaur Microbial Pathogenesis.2021; 151: 104733. CrossRef
Immune induction by adjuvanted Leishmania donovani vaccines against the visceral leishmaniasis in BALB/c mice Deepak Kumar Goyal, Poonam Keshav, Sukhbir Kaur Immunobiology.2021; 226(2): 152057. CrossRef
Adjuvant effects of TLR agonist gardiquimod admixed with Leishmania vaccine in mice model of visceral leishmaniasis Deepak Kumar Goyal, Poonam Keshav, Sukhbir Kaur Infection, Genetics and Evolution.2021; 93: 104947. CrossRef
The potential of live attenuated vaccines against Cutaneous Leishmaniasis A. Zabala-Peñafiel, D. Todd, H. Daneshvar, R. Burchmore Experimental Parasitology.2020; 210: 107849. CrossRef
Immunization with a recombinant fusion protein protects mice against Helicobacter pylori infection Amir Ghasemi, Nazanin Mohammad, Josef Mautner, Mehrnaz Taghipour Karsabet, Jafar Amani, Abolfazl Ardjmand, Zarichehr Vakili Vaccine.2018; 36(34): 5124. CrossRef
Evaluation of vaccinal effectiveness of preparations containing membrane antigens of Leishmania (L.) amazonensis in experimental cutaneous leishmaniasis model João G. Ribeiro, Amália S. Ferreira, Sharon R.A. Macedo, Norton R.D.L.P. Rossi, Mayara C.P. da Silva, Rosane N.M. Guerra, Neuza B. de Barros, Roberto Nicolete International Immunopharmacology.2017; 47: 227. CrossRef
Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis Ankita Thakur, Harpreet Kaur, Sukhbir Kaur Parasitology International.2015; 64(1): 70. CrossRef
Ox40L–Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major Rashmi Tuladhar, Steve Oghumu, Ran Dong, Allison Peterson, Arlene H. Sharpe, Abhay R. Satoskar Experimental Parasitology.2015; 148: 49. CrossRef
Identification of immunodominant Leishmania major antigenic markers of the early C57BL/6 and BALB/c mice infection stages A. Sassi, O. Kaak, A. Ben Ammar Elgaied Parasite Immunology.2015; 37(10): 544. CrossRef
Th1 Platform Immune Responses Against Leishmania major Induced by Thiol-Specific Antioxidant-Based DNA Vaccines Fatemeh Tabatabaie, Mehdi Mahdavi, Sobhan Faezi, Abdolhossein Dalimi, Zohreh Sharifi, Lame Akhlaghi, Fatemeh Ghaffarifar Jundishapur Journal of Microbiology.2014;[Epub] CrossRef
Studies on the protective efficacy and immunogenicity of Hsp70 and Hsp83 based vaccine formulations in Leishmania donovani infected BALB/c mice Jaspreet Kaur, Tejinder Kaur, Sukhbir Kaur Acta Tropica.2011; 119(1): 50. CrossRef
Protective effect of lectin from Synadenium carinatum on Leishmania amazonensis infection in BALB/c mice Sandra R. Afonso-Cardoso, Flávio H. Rodrigues, Márcio A.B. Gomes, Adriano G. Silva, Ademir Rocha, Aparecida H.B. GuimarÃes, Ignês Candeloro, Sílvio Favoreto, Marcelo S. Ferreira, Maria A. de Souza The Korean Journal of Parasitology.2007; 45(4): 255. CrossRef
Purification and biochemical characterization of two novel antigens from Leishmania major promastigotes Majid Zeinali, Sussan K. Ardestani, Amina Kariminia The Korean Journal of Parasitology.2007; 45(4): 287. CrossRef